Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

NVCT

Nuvectis Pharma Inc

May 03 • 04:00PM ET

8.14

Dollar change +1.38
Percentage change 20.41	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VTWO IWC VTWG RYLD VTHR URTY

Index	RUT	P/E	-	EPS (ttm)	-1.40	Insider Own	60.91%	Shs Outstand	17.42M	Perf Week	25.23%
Market Cap	149.53M	Forward P/E	-	EPS next Y	-1.78	Insider Trans	0.04%	Shs Float	7.18M	Perf Month	5.58%
Income	-22.26M	PEG	-	EPS next Q	-0.40	Inst Own	8.46%	Short Float	11.46%	Perf Quarter	15.46%
Sales	0.00M	P/S	-	EPS this Y	-6.53%	Inst Trans	28.35%	Short Ratio	8.46	Perf Half Y	-11.43%
Book/sh	0.70	P/B	11.62	EPS next Y	-16.85%	ROA	-112.45%	Short Interest	0.82M	Perf Year	-43.20%
Cash/sh	1.04	P/C	7.82	EPS next 5Y	-	ROE	-168.51%	52W Range	5.92 - 18.65	Perf YTD	-2.40%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-182.44%	52W High	-56.35%	Beta	0.44
Dividend TTM	-	Quick Ratio	2.75	Sales past 5Y	0.00%	Gross Margin	-	52W Low	37.50%	ATR (14)	0.72
Dividend Ex-Date	-	Current Ratio	2.75	EPS Y/Y TTM	5.49%	Oper. Margin	0.00%	RSI (14)	59.54	Volatility	12.09% 8.95%
Employees	13	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	22.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	16.86%	Payout	-	Rel Volume	1.09	Prev Close	6.76
Sales Surprise	-	EPS Surprise	0.00%	Sales Q/Q	-	Earnings	Mar 06 BMO	Avg Volume	97.20K	Price	8.14
SMA20	17.92%	SMA50	-1.84%	SMA200	-18.34%	Trades		Volume	106,290	Change	20.41%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-13-22	Initiated	Ladenburg Thalmann	Buy	$21

Apr-08-24 08:30AM	Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines (GlobeNewswire)
Apr-02-24 04:30PM	5 Healthcare Stocks to Buy for 2024 (InvestorPlace)
Mar-19-24 08:00AM	Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting (GlobeNewswire) -16.08%
Mar-15-24 08:00AM	Nuvectis Pharma to Present at the 36th Annual Roth Conference (GlobeNewswire) +20.22%
Mar-14-24 09:00AM	Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer (GlobeNewswire) -5.08%
11:52PM	Loading…
Mar-05-24 11:52PM	NVCT Stock Earnings: Nuvectis Pharma Misses EPS for Q4 2023 (InvestorPlace)
08:31AM	Nuvectis Pharma Inc (NVCT) Reports Increased Net Loss in FY 2023 Despite Clinical Progress (GuruFocus.com)
08:00AM	Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights (GlobeNewswire)
Feb-09-24 08:32AM	Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
08:00AM	Nuvectis Pharma Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Jan-03-24 08:00AM	Nuvectis Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-18-23 08:00AM	Nuvectis Pharma, Inc. Announces a Collaboration with Mayo Clinic to Evaluate NXP800 in an Investigator-Sponsored Clinical Trial in Cholangiocarcinoma (GlobeNewswire)
Nov-08-23 08:00AM	Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights (GlobeNewswire) -7.83%
Oct-24-23 08:00AM	Nuvectis Pharma Announces Upcoming Poster Presentation for NXP800 at the 2023 AACR Special Conference on Endometrial Cancer (GlobeNewswire)
Oct-16-23 09:35AM	Down -36.49% in 4 Weeks, Here's Why You Should You Buy the Dip in Nuvectis Pharma, Inc. (NVCT) (Zacks) +15.87%
07:30PM	Loading…
Sep-25-23 07:30PM	Nuvectis Pharma Announces Updated Date and Time for the 2023 Cantor Global Healthcare Conference Corporate Presentation (GlobeNewswire)
Sep-21-23 08:00AM	Nuvectis Pharma Announces Upcoming Presentations for NXP800 and NXP900 (GlobeNewswire)
Sep-12-23 08:00AM	Nuvectis Pharma Announces Initiation of the NXP900 Phase 1a Clinical Trial (GlobeNewswire)
Sep-06-23 08:00AM	Nuvectis Pharma to Host KOL Event to Discuss Its Two Precision Medicine Clinical-Stage Drug Candidates, NXP800 and NXP900 (GlobeNewswire)
Sep-01-23 08:00AM	Nuvectis Pharma Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Aug-17-23 08:00AM	Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA to NXP800 for the Treatment of Cholangiocarcinoma (GlobeNewswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
Aug-10-23 06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 08:00AM	Nuvectis Pharma, Inc. Reports Second Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research)
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research) +7.41%
06:51AM	Loading…
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research)
06:51AM	Daily Vickers Top Buyers & Sellers for 08/01/2023 (Argus Research)
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
07:58AM	Daily Vickers Top Buyers & Sellers for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research)
07:16AM	Daily Vickers Top Buyers & Sellers for 07/25/2023 (Argus Research)
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research) +5.18%
07:23AM	Daily Vickers Top Buyers & Sellers for 07/21/2023 (Argus Research)
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
06:55AM	Daily Vickers Top Buyers & Sellers for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
07:10AM	Daily Vickers Top Buyers & Sellers for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research)
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research)
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research)
06:50AM	Daily Vickers Top Buyers & Sellers for 07/14/2023 (Argus Research)
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research)
07:02AM	Daily Vickers Top Buyers & Sellers for 07/13/2023 (Argus Research)
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research)
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
06:08AM	Daily Vickers Top Buyers & Sellers for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research) +5.97%
06:56AM	Daily Vickers Top Buyers & Sellers for 07/10/2023 (Argus Research)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research)
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research)
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research)
Jun-28-23 07:13AM	Daily Vickers Top Buyers & Sellers for 06/28/2023 (Argus Research)
06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research)
06:46AM	Daily Vickers Top Buyers & Sellers for 06/27/2023 (Argus Research)
Jun-26-23 06:41AM	Daily Vickers Top Buyers & Sellers for 06/26/2023 (Argus Research)
Jun-21-23 07:20AM	Daily Vickers Top Buyers & Sellers for 06/21/2023 (Argus Research)
Jun-20-23 08:00AM	Nuvectis Pharma Set to Join the Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
06:35AM	Daily Vickers Top Buyers & Sellers for 06/20/2023 (Argus Research)
Jun-18-23 08:03AM	Charles Mosseri-Marlio Buys 1.3% More Nuvectis Pharma Shares \ (Simply Wall St.)
Jun-05-23 08:50AM	Here's Why Momentum in Nuvectis Pharma, Inc. (NVCT) Should Keep going (Zacks)
Jun-01-23 04:48AM	Zacks.com featured highlights Corsair Gaming, Nuvectis Pharma and WisdomTree (Zacks)
May-31-23 06:22AM	3 Best Breakout Stocks Worth Buying for Superlative Returns (Zacks)
May-19-23 08:50AM	Here's What Could Help Nuvectis Pharma, Inc. (NVCT) Maintain Its Recent Price Strength (Zacks)
May-15-23 09:55AM	Wall Street Analysts Think Nuvectis Pharma, Inc. (NVCT) Could Surge 29.35%: Read This Before Placing a Bet (Zacks) +6.19%
08:00AM	Nuvectis Pharma Announces FDA Clearance of NXP900 IND (GlobeNewswire)
May-10-23 08:00AM	Nuvectis Pharma, Inc. Reports First Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
May-09-23 01:34PM	We're Not Very Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Rate (Simply Wall St.)
May-02-23 06:46AM	Daily Vickers Top Insider Picks for 05/02/2023 (Argus Research) -5.07%
May-01-23 06:45AM	Daily Vickers Top Insider Picks for 05/01/2023 (Argus Research)
Apr-28-23 07:04AM	Daily Vickers Top Insider Picks for 04/28/2023 (Argus Research)
Apr-27-23 10:14AM	Correction: Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference (GlobeNewswire)
08:00AM	Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference (GlobeNewswire)
06:47AM	Daily Vickers Top Insider Picks for 04/27/2023 (Argus Research)
Apr-26-23 06:26AM	Daily Vickers Top Insider Picks for 04/26/2023 (Argus Research)
Apr-20-23 07:03AM	Daily Vickers Top Insider Picks for 04/20/2023 (Argus Research) -5.33%
Apr-19-23 06:53AM	Daily Vickers Top Insider Picks for 04/19/2023 (Argus Research)
Apr-18-23 08:00AM	Nuvectis Pharma Recaps Poster Presentation Highlights for NXP800's Activity in Cholangiocarcinoma PDX Models at the 2023 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Apr-17-23 06:54AM	Daily Vickers Top Insider Picks for 04/17/2023 (Argus Research)
Apr-14-23 06:37AM	Daily Vickers Top Insider Picks for 04/14/2023 (Argus Research)
Apr-13-23 06:52AM	Daily Vickers Top Insider Picks for 04/13/2023 (Argus Research)
Apr-12-23 07:07AM	Daily Vickers Top Insider Picks for 04/12/2023 (Argus Research)
Apr-11-23 06:58AM	Daily Vickers Top Insider Picks for 04/11/2023 (Argus Research) +9.57%
Apr-10-23 08:00AM	Nuvectis Pharma Announces Initiation of the Phase 1b Study for NXP800 in Platinum-Resistant, ARID1a-Mutated Ovarian Carcinoma (GlobeNewswire)
06:44AM	Daily Vickers Top Insider Picks for 04/10/2023 (Argus Research)
Apr-07-23 07:44AM	Daily Vickers Top Insider Picks for 04/07/2023 (Argus Research)
Apr-06-23 07:20AM	Daily Vickers Top Insider Picks for 04/06/2023 (Argus Research)
Apr-05-23 07:19AM	Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders have recently purchased stock and their bets paid off last week as company hit US$198m market cap (Simply Wall St.) -5.75%
06:11AM	Daily Vickers Top Insider Picks for 04/05/2023 (Argus Research)
Apr-04-23 07:08AM	Daily Vickers Top Insider Picks for 04/04/2023 (Argus Research)

Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BENTSUR RON	Chairman & CEO	Mar 18 '24	Buy	10.29	5,000	51,450	3,242,484	Mar 19 08:00 AM
BENTSUR RON	Chairman & CEO	Oct 10 '23	Buy	11.08	640	7,091	3,237,484	Oct 12 04:05 PM
BENTSUR RON	Chairman & CEO	Oct 09 '23	Buy	11.19	830	9,288	3,236,844	Oct 10 08:30 AM
BENTSUR RON	Chairman & CEO	Oct 06 '23	Buy	11.27	250	2,818	3,236,014	Oct 10 08:30 AM
BENTSUR RON	Chairman & CEO	Oct 05 '23	Buy	11.09	1,400	15,526	3,235,764	Oct 06 08:37 AM
BENTSUR RON	Chairman & CEO	Oct 04 '23	Buy	10.95	1,820	19,929	3,234,364	Oct 06 08:37 AM
BENTSUR RON	Chairman & CEO	Aug 16 '23	Buy	15.15	115	1,742	3,232,544	Aug 16 04:05 PM
BENTSUR RON	Chairman & CEO	Aug 15 '23	Buy	14.34	235	3,370	3,232,429	Aug 16 04:05 PM
BENTSUR RON	Chairman & CEO	Aug 11 '23	Buy	14.66	180	2,639	3,232,194	Aug 11 06:07 PM
BENTSUR RON	Chairman & CEO	Aug 08 '23	Buy	14.83	120	1,780	3,232,014	Aug 11 06:07 PM
Mosseri Marlio Charles	10% Owner	Jul 31 '23	Buy	13.88	860	11,937	2,595,000	Aug 01 08:00 AM
Mosseri Marlio Charles	10% Owner	Jul 28 '23	Buy	13.91	2,584	35,943	2,594,140	Jul 31 08:00 AM
Mosseri Marlio Charles	10% Owner	Jul 27 '23	Buy	13.98	1,556	21,753	2,591,556	Jul 28 08:00 AM
Mosseri Marlio Charles	10% Owner	Jul 26 '23	Buy	13.97	10,000	139,700	2,590,000	Jul 27 06:52 AM
Mosseri Marlio Charles	10% Owner	Jul 21 '23	Buy	14.61	2,844	41,551	2,580,000	Jul 24 04:45 PM
BENTSUR RON	Chairman & CEO	Jul 21 '23	Buy	14.85	225	3,341	3,231,894	Jul 24 04:45 PM
Mosseri Marlio Charles	10% Owner	Jul 20 '23	Buy	14.40	5,394	77,674	2,577,156	Jul 24 04:45 PM
BENTSUR RON	Chairman & CEO	Jul 20 '23	Buy	15.06	110	1,657	3,231,669	Jul 24 04:45 PM
Mosseri Marlio Charles	10% Owner	Jul 19 '23	Buy	14.84	8,000	118,720	2,571,762	Jul 20 06:30 AM
BENTSUR RON	Chairman & CEO	Jul 19 '23	Buy	14.33	200	2,866	3,231,559	Jul 20 06:30 AM
Mosseri Marlio Charles	10% Owner	Jul 18 '23	Buy	14.84	9,149	135,771	2,563,762	Jul 19 08:06 AM
BENTSUR RON	Chairman & CEO	Jul 14 '23	Buy	15.03	150	2,254	3,231,359	Jul 18 08:34 AM
Mosseri Marlio Charles	10% Owner	Jul 12 '23	Buy	15.09	3,285	49,571	2,554,613	Jul 13 08:30 AM
Mosseri Marlio Charles	10% Owner	Jul 11 '23	Buy	15.36	10,000	153,600	2,551,328	Jul 12 08:30 AM
Mosseri Marlio Charles	10% Owner	Jul 07 '23	Buy	15.19	8,948	135,920	2,541,328	Jul 10 08:00 AM
BENTSUR RON	Chairman & CEO	Jul 07 '23	Buy	16.19	110	1,781	3,231,209	Jul 18 08:34 AM
Mosseri Marlio Charles	10% Owner	Jul 06 '23	Buy	15.01	3,179	47,717	2,532,380	Jul 07 08:04 AM
BENTSUR RON	Chairman & CEO	Jul 06 '23	Buy	14.88	320	4,762	3,231,099	Jul 07 08:03 AM
Mosseri Marlio Charles	10% Owner	Jul 05 '23	Buy	15.52	1,176	18,252	2,529,201	Jul 06 07:45 AM
Mosseri Marlio Charles	10% Owner	Jun 26 '23	Buy	16.46	16,760	275,870	2,528,025	Jun 27 08:45 AM
BENTSUR RON	Chairman & CEO	Jun 26 '23	Buy	16.50	750	12,375	3,230,779	Jun 27 08:45 AM
Mosseri Marlio Charles	10% Owner	Jun 23 '23	Buy	17.43	73,175	1,275,440	2,511,265	Jun 26 08:45 AM
Mosseri Marlio Charles	10% Owner	Jun 22 '23	Buy	17.73	6,999	124,092	2,438,090	Jun 23 08:59 AM
Mosseri Marlio Charles	10% Owner	Jun 21 '23	Buy	17.71	6,091	107,872	2,431,091	Jun 23 08:59 AM
BENTSUR RON	Chairman & CEO	Jun 21 '23	Buy	17.88	500	8,940	3,230,029	Jun 22 08:42 AM
Mosseri Marlio Charles	10% Owner	Jun 16 '23	Buy	17.75	12,700	225,425	2,425,000	Jun 20 08:25 AM
Mosseri Marlio Charles	10% Owner	Jun 15 '23	Buy	17.71	32,124	568,848	2,412,300	Jun 16 06:46 AM
BENTSUR RON	Chairman & CEO	Jun 08 '23	Buy	17.53	120	2,104	3,229,529	Jun 08 09:28 PM
BENTSUR RON	Chairman & CEO	Jun 07 '23	Buy	17.41	230	4,004	3,229,409	Jun 08 09:28 PM
BENTSUR RON	Chairman & CEO	May 31 '23	Buy	17.28	330	5,702	3,229,179	Jun 01 08:00 AM
BENTSUR RON	Chairman & CEO	May 24 '23	Buy	17.49	200	3,498	3,228,849	May 26 09:29 AM
BENTSUR RON	Chairman & CEO	May 16 '23	Buy	17.02	320	5,448	3,228,649	May 18 07:00 AM

Open in Screener

XAIR

Beyond Air Inc

May 03 • 04:00PM ET

1.30

Dollar change +0.08
Percentage change 6.56	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO VTWO IWC VTWG VTWV URTY UWM

Index	RUT	P/E	-	EPS (ttm)	-2.11	Insider Own	22.91%	Shs Outstand	45.90M	Perf Week	11.59%
Market Cap	59.67M	Forward P/E	-	EPS next Y	-1.75	Insider Trans	13.61%	Shs Float	35.39M	Perf Month	-20.25%
Income	-66.70M	PEG	-	EPS next Q	-0.47	Inst Own	22.44%	Short Float	9.06%	Perf Quarter	-24.86%
Sales	0.69M	P/S	86.48	EPS this Y	-3.98%	Inst Trans	10.31%	Short Ratio	10.48	Perf Half Y	-44.21%
Book/sh	0.59	P/B	2.22	EPS next Y	9.62%	ROA	-105.99%	Short Interest	3.21M	Perf Year	-78.00%
Cash/sh	0.69	P/C	1.89	EPS next 5Y	-	ROE	-185.90%	52W Range	1.06 - 6.36	Perf YTD	-33.67%
Dividend Est.	-	P/FCF	-	EPS past 5Y	9.16%	ROI	-179.27%	52W High	-79.56%	Beta	-0.04
Dividend TTM	-	Quick Ratio	3.26	Sales past 5Y	-54.80%	Gross Margin	-395.86%	52W Low	22.64%	ATR (14)	0.14
Dividend Ex-Date	-	Current Ratio	3.39	EPS Y/Y TTM	-25.60%	Oper. Margin	-9341.22%	RSI (14)	47.10	Volatility	10.58% 11.65%
Employees	98	Debt/Eq	0.81	Sales Y/Y TTM	-	Profit Margin	-9680.99%	Recom	1.00	Target Price	12.60
Option/Short	Yes / Yes	LT Debt/Eq	0.79	EPS Q/Q	-17.28%	Payout	-	Rel Volume	1.07	Prev Close	1.22
Sales Surprise	-12.96%	EPS Surprise	7.41%	Sales Q/Q	-	Earnings	Feb 12 AMC	Avg Volume	306.15K	Price	1.30
SMA20	-1.25%	SMA50	-16.57%	SMA200	-38.50%	Trades		Volume	326,733	Change	6.56%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-28-23	Initiated	Piper Sandler	Overweight	$10
Jun-15-23	Initiated	BTIG Research	Buy	$15
Apr-28-21	Initiated	Truist	Buy	$12
Oct-22-19	Initiated	Oppenheimer	Outperform	$9

May-01-24 07:00AM	Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting (GlobeNewswire)
Mar-21-24 12:00PM	Beyond Air (XAIR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) +5.84%
Mar-20-24 09:00AM	Beyond Air Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants (GlobeNewswire)
Feb-13-24 08:51AM	Beyond Air, Inc. (NASDAQ:XAIR) Q3 2024 Earnings Call Transcript (Insider Monkey) -17.67%
Feb-12-24 04:05PM	Beyond Air Reports Financial Results for Third Quarter of Fiscal Year 2024 (GlobeNewswire) +14.97%
08:00AM	Loading…
Jan-18-24 08:00AM	Beyond Air Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast (GlobeNewswire) -5.02%
Dec-27-23 07:30AM	Beyond Cancer Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors (GlobeNewswire)
Dec-21-23 01:40AM	Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc (GuruFocus.com) +12.04%
Nov-15-23 04:05PM	Beyond Air To Participate in the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire) +23.57%
Nov-14-23 10:00AM	Beyond Air, Inc. (NASDAQ:XAIR) Q2 2024 Earnings Call Transcript (Insider Monkey) -31.03%
Nov-13-23 04:05PM	Beyond Air Reports Financial Results for Second Quarter of Fiscal Year 2024 (GlobeNewswire)
Nov-03-23 12:00PM	Beyond Cancer Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting (GlobeNewswire) -6.91%
Oct-19-23 04:05PM	Beyond Air Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast (GlobeNewswire)
Oct-17-23 04:05PM	Beyond Air To Participate in the Truist Securities BioPharma Symposium (GlobeNewswire) +8.48%
07:30AM	Beyond Cancer Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice (GlobeNewswire)
07:30AM	Loading…
Oct-16-23 07:30AM	Beyond Cancer Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
07:00AM	Beyond Air Receives Innovative Technology Contract from Vizient for LungFit PH (GlobeNewswire)
Oct-04-23 07:30AM	Beyond Cancer Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Oct-02-23 04:05PM	Beyond Air To Participate in the Roth MKM 2023 Healthcare Opportunities Conference (GlobeNewswire) -7.79%
Sep-27-23 09:00AM	Beyond Cancer to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual Meeting (GlobeNewswire)
Sep-18-23 04:05PM	Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder (GlobeNewswire) -7.95%
Sep-07-23 07:30AM	Beyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region (GlobeNewswire)
Sep-06-23 07:00AM	Beyond Air® To Participate in the 2023 Cantor Global Healthcare Conference (GlobeNewswire)
Aug-10-23 04:05PM	Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024 (GlobeNewswire)
Aug-08-23 09:55AM	2 Strong Buy Penny Stocks That Could Rally All the Way to $10 (or More) (TipRanks) +13.35%
Aug-07-23 04:05PM	Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD) (GlobeNewswire)
Aug-01-23 04:05PM	Beyond Air® To Participate in BTIGs 2023 Virtual Biotechnology Conference (GlobeNewswire)
Jul-28-23 10:13AM	Block upgraded, Southwest downgraded: Wall Street's top analyst calls (The Fly) +7.12%
Jul-24-23 04:05PM	Beyond Air® Schedules First Fiscal Quarter 2024 Financial Results Conference Call and Webcast (GlobeNewswire) -6.11%
Jun-22-23 04:05PM	Beyond Air® Reports Financial Results for Fourth Quarter and Fiscal Year-End 2023 (GlobeNewswire)
04:10PM	Loading…
Jun-15-23 04:10PM	Beyond Air® Secures up to $40 Million Debt Financing (GlobeNewswire)
04:05PM	Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem (GlobeNewswire)
Jun-09-23 06:34AM	Daily Vickers Top Insider Picks for 06/09/2023 (Argus Research)
Jun-08-23 06:43AM	Daily Vickers Top Insider Picks for 06/08/2023 (Argus Research)
Jun-07-23 08:25AM	Daily Vickers Top Insider Picks for 06/07/2023 (Argus Research)
Jun-06-23 06:34AM	Daily Vickers Top Insider Picks for 06/06/2023 (Argus Research)
Jun-05-23 06:44AM	Daily Vickers Top Insider Picks for 06/05/2023 (Argus Research)
Jun-02-23 06:56AM	Daily Vickers Top Insider Picks for 06/02/2023 (Argus Research)
Jun-01-23 06:29AM	Daily Vickers Top Insider Picks for 06/01/2023 (Argus Research)
May-31-23 06:40AM	Daily Vickers Top Insider Picks for 05/31/2023 (Argus Research)
May-30-23 06:50AM	Daily Vickers Top Insider Picks for 05/30/2023 (Argus Research)
May-26-23 06:59AM	Daily Vickers Top Insider Picks for 05/26/2023 (Argus Research)
May-25-23 06:38AM	Daily Vickers Top Insider Picks for 05/25/2023 (Argus Research)
May-24-23 06:43AM	Daily Vickers Top Insider Picks for 05/24/2023 (Argus Research)
May-23-23 06:33AM	Daily Vickers Top Insider Picks for 05/23/2023 (Argus Research)
May-22-23 07:49AM	Daily Vickers Top Insider Picks for 05/22/2023 (Argus Research)
May-19-23 07:03AM	Daily Vickers Top Insider Picks for 05/19/2023 (Argus Research)
May-18-23 06:39AM	Daily Vickers Top Insider Picks for 05/18/2023 (Argus Research)
May-17-23 06:35AM	Daily Vickers Top Insider Picks for 05/17/2023 (Argus Research)
May-16-23 04:05PM	Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and Webcast (GlobeNewswire)
Apr-19-23 09:00AM	Beyond Cancer Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the American Association for Cancer Research (AACR) 2023 Annual Meeting (GlobeNewswire)
Mar-31-23 06:36AM	Daily Vickers Top Buyers & Sellers for 03/31/2023 (Argus Research)
Mar-23-23 04:05PM	Beyond Air® Appoints Jeff Myers, M.D. Ph.D. as Chief Medical Officer (GlobeNewswire) -5.84%
Mar-14-23 04:35PM	Beyond Cancer to Present Two Posters for Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2023 AACR Annual Meeting (GlobeNewswire) +6.59%
Mar-10-23 07:04AM	Daily Vickers Top Buyers & Sellers for 03/10/2023 (Argus Research)
Feb-22-23 07:00AM	Beyond Air® Announces Participation at Two Upcoming Investor Conferences in March 2023 (GlobeNewswire)
Feb-09-23 04:05PM	Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2023 (GlobeNewswire) -6.21%
Jan-30-23 07:00AM	Beyond Cancer® Appoints Gavin Choy, PharmD as Chief Operating Officer (GlobeNewswire)
Jan-24-23 04:05PM	Beyond Cancer® Announces Sponsored Research Agreement with Stanford and Appointment of Frederick M. Dirbas, MD and Mark D. Pegram, MD to Scientific Advisory Board (GlobeNewswire)
Jan-17-23 04:05PM	Beyond Air® Schedules Third Fiscal Quarter 2023 Financial Results Conference Call and Webcast (GlobeNewswire)
Dec-13-22 09:25AM	Beyond Cancer® Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide (UNO) Induced a Systemic Response that Prevents Metastases (GlobeNewswire) +9.26%
Nov-17-22 04:05PM	Beyond Air® To Participate in Pipers 34th Annual Healthcare Conference (GlobeNewswire) -6.08%
Nov-10-22 09:00AM	Beyond Cancer Presents Promising New In Vivo Data Showing Ultra-High Concentration Nitric Oxide Therapy (UNO) in Combination with Anti-PD-1 During the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting (GlobeNewswire)
Nov-08-22 04:05PM	Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2023 (GlobeNewswire)
Oct-24-22 07:30AM	Beyond Air® Announces Positive Data for Inhaled Nitric Oxide (NO) to Treat COVID-19 with LungFit® PRO in a Poster Presentation at IDWeek 2022 (GlobeNewswire)
Oct-20-22 04:05PM	Beyond Air® Schedules Second Fiscal Quarter 2023 Financial Results Conference Call and Webcast (GlobeNewswire) +7.55%
Oct-17-22 04:05PM	Beyond Air® Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with (NO) using the LungFit® GO at the CHEST Annual Meeting 2022 (GlobeNewswire)
Oct-05-22 08:00AM	Beyond Cancer to Present Pre-Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2022 SITC Annual Meeting (GlobeNewswire)
Oct-03-22 07:30AM	Beyond Air® Announces that Annals of the American Thoracic Society Published a Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis (GlobeNewswire)
Sep-16-22 04:05PM	Beyond Air® To Participate in Three Upcoming Investor Conferences (GlobeNewswire)
Aug-23-22 08:00AM	Beyond Air® Affiliate Beyond Cancer Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov) (GlobeNewswire) +10.12%
Aug-11-22 04:05PM	Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2023 (GlobeNewswire)
Jul-27-22 04:05PM	Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast (GlobeNewswire)
Jun-28-22 04:10PM	Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022 (GlobeNewswire) -7.81%
04:05PM	Beyond Airs LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure (GlobeNewswire)
Jun-14-22 04:30PM	Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th (GlobeNewswire)
Jun-01-22 07:00AM	Beyond Cancer Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer (GlobeNewswire)
May-17-22 04:05PM	Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022 (GlobeNewswire) +7.84%
07:00AM	Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer (GlobeNewswire)
May-16-22 07:05AM	Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast (GlobeNewswire)
May-06-22 06:29AM	Loss-Making Beyond Air, Inc. (NASDAQ:XAIR) Expected To Breakeven In The Medium-Term (Simply Wall St.)
Apr-25-22 04:05PM	Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022 (GlobeNewswire) +12.02%
07:00AM	Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022 (GlobeNewswire)
Apr-18-22 07:00AM	Beyond Air® to Participate in Three Upcoming Medical Conferences (GlobeNewswire)
Apr-11-22 07:00AM	Beyond Cancer Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect (GlobeNewswire) -7.95%
Mar-08-22 04:35PM	Beyond Cancer to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting (GlobeNewswire)
Feb-22-22 04:52AM	Beyond Air (NASDAQ:XAIR) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Feb-10-22 04:05PM	Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022 (GlobeNewswire)
Feb-08-22 08:00AM	Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022 (GlobeNewswire)
Feb-03-22 04:05PM	Beyond Air® Announces Two Appointments to Beyond Cancer Board of Directors (GlobeNewswire)
Jan-27-22 08:00AM	Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast (GlobeNewswire) -5.94%
Dec-14-21 09:15AM	Beyond Air Inc (XAIR) CEO and Chairman of the Board Steven A. Lisi Bought $341,200 of Shares (GuruFocus.com) +9.35%
Dec-10-21 09:14AM	Implied Volatility Surging for Beyond Air (XAIR) Stock Options (Zacks)
Dec-09-21 08:30AM	Beyond Air® Provides Regulatory Update for LungFit® PH (GlobeNewswire) -20.45%
05:56AM	Beyond Air Slides After LungFit Launch Delay (Investing.com)
Dec-01-21 08:00AM	Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer (GlobeNewswire)
Nov-18-21 04:05PM	Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer Private Placement (GlobeNewswire) -6.49%
Nov-11-21 04:05PM	Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2022 (GlobeNewswire)
Nov-04-21 03:01PM	Beyond Air, Inc. (XAIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks) -9.44%
07:30AM	Beyond Air® Announces Formation of Beyond Cancer, a New Private Company Dedicated to Oncology Utilizing Ultra-High Concentration Nitric Oxide to Treat Solid Tumors (GlobeNewswire)

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in developing a platform for nitric oxide generators and delivery systems. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Avniel Amir	Chief Business Officer	Dec 28 '23	Sale	2.05	13,733	28,217	0	Dec 29 04:23 PM
Avniel Amir	Chief Business Officer	Dec 28 '23	Sale	2.06	11,267	23,234	685,760	Dec 29 04:23 PM
Myers Jeff Lynn	Chief Medical Officer	Dec 27 '23	Sale	2.21	3,423	7,579	46,577	Dec 29 04:15 PM
Carey Robert	Director	Dec 18 '23	Buy	1.64	1,200,000	1,962,000	2,374,454	Dec 19 05:13 PM
Lisi Steven A.	CEO and Chairman of the Board	Dec 18 '23	Buy	1.63	77,775	126,797	1,536,471	Dec 19 05:15 PM
Gaul Michael A.	Chief Operating Officer	Nov 16 '23	Buy	1.77	10,000	17,700	88,150	Nov 17 04:15 PM
Carey Robert	Director	Aug 28 '23	Buy	2.69	250,000	673,750	1,225,160	Aug 29 04:10 PM
Carey Robert	Director	Aug 21 '23	Buy	2.76	75,050	207,453	975,160	Aug 22 04:10 PM
Carey Robert	Director	Aug 18 '23	Buy	2.64	13,614	35,940	900,110	Aug 22 04:10 PM
Gaul Michael A.	Chief Operating Officer	Jun 30 '23	Buy	4.51	5,000	22,550	78,150	Jul 05 04:05 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

NVCT

Nuvectis Pharma Inc

XAIR

Beyond Air Inc

Upgrade your FINVIZ experience